Mo Li

机构：Tianjin University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Beijing Jiaotong University, Soochow University, National Clinical Research Center for Digestive Diseases, Peking University People's Hospital, King Abdullah University of Science and Technology · ORCID：0000-0003-0827-8907

发表论文 250 篇 · 总被引 10708 次 · h-index 49

代表论文

• Targeting KRAS: from metabolic regulation to cancer treatment (2025 · Molecular Cancer · 被引 62)
• Multiomics Analyses With Stool-Type Stratification in Patient Cohorts and Blautia Identification as a Potential Bacterial Modulator in Type 2 Diabetes Mellitus (2023 · Diabetes · 被引 30)
• Quantitative haplotype-resolved analysis of mitochondrial DNA heteroplasmy in Human single oocytes, blastoids, and pluripotent stem cells (2023 · Nucleic Acids Research · 被引 23)
• Modulation of the microhomology-mediated end joining pathway suppresses large deletions and enhances homology-directed repair following CRISPR-Cas9-induced DNA breaks (2024 · BMC Biology · 被引 18)
• Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury (2024 · Stem Cell Research & Therapy · 被引 16)
• An open-source, automated, and cost-effective platform for COVID-19 diagnosis and rapid portable genomic surveillance using nanopore sequencing (2023 · Scientific Reports · 被引 13)